The company had $82.8 million in cash, cash equivalents, and short-term investments as of March 31, 2024. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on RPHM: Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update Reneo Pharmaceuticals reports Q4 EPS (70c), consensus (58c) RPHM Earnings Report this Week: Is It a Buy, Ahead of Earnings? Disclaimer & DisclosureReport an Issue